Vor Biopharma Inc.
NASDAQ:VOR
0.9342 (USD) • At close September 18, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|
| Revenue
| 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue
| 3.492 | 8.96 | 4.451 | 1.387 | 0.091 | 0.02 |
| Gross Profit
| -3.492 | -8.96 | -4.451 | -1.387 | -0.091 | -0.02 |
| Gross Profit Ratio
| 0 | 0 | 0 | 0 | 0 | 0 |
| Reseach & Development Expenses
| 94.315 | 64.55 | 47.529 | 31.618 | 6.2 | 2.433 |
| General & Administrative Expenses
| 31.721 | 28.868 | 21.489 | 11.748 | 4.217 | 0.427 |
| Selling & Marketing Expenses
| -3.492 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 28.229 | 28.868 | 21.489 | 11.748 | 4.217 | 0.427 |
| Other Expenses
| 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses
| 122.544 | 93.418 | 69.018 | 43.366 | 10.417 | 2.86 |
| Operating Income
| -126.036 | -93.418 | -69.018 | -43.366 | -10.417 | -2.86 |
| Operating Income Ratio
| 0 | 0 | 0 | 0 | 0 | 0 |
| Total Other Income Expenses Net
| 8.173 | 1.324 | 0.119 | 0.029 | -0.422 | -0.289 |
| Income Before Tax
| -117.863 | -92.094 | -68.899 | -43.337 | -10.839 | -4.152 |
| Income Before Tax Ratio
| 0 | 0 | 0 | 0 | 0 | 0 |
| Income Tax Expense
| 0 | -1.324 | -0.119 | 0.428 | 0.608 | -0.289 |
| Net Income
| -117.863 | -90.77 | -68.78 | -43.337 | -11.447 | -4.152 |
| Net Income Ratio
| 0 | 0 | 0 | 0 | 0 | 0 |
| EPS
| -1.75 | -2.29 | -1.85 | -1.17 | -0.31 | -0.73 |
| EPS Diluted
| -1.75 | -2.29 | -1.85 | -1.17 | -0.31 | -0.73 |
| EBITDA
| -122.544 | -90.893 | -67.584 | -42.732 | -10.172 | -2.84 |
| EBITDA Ratio
| 0 | 0 | 0 | 0 | 0 | 0 |